Fortrea Holdings Inc. (FTRE)
USD 6.33
(-6.77%)
USD 6.33
(-6.77%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.56 Billion USD | 3329.22% |
| 2022 | -48.6 Million USD | -179.31% |
| 2021 | -17.4 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.07 Billion USD | -32.54% |
| 2024 Q1 | 1.59 Billion USD | 1.71% |
| 2023 Q4 | 1.56 Billion USD | -0.58% |
| 2023 Q3 | 1.57 Billion USD | 0.95% |
| 2023 Q1 | 1.54 Billion USD | 3275.72% |
| 2023 Q2 | 1.56 Billion USD | 1.32% |
| 2023 FY | 1.56 Billion USD | 3329.22% |
| 2022 Q4 | -48.6 Million USD | 0.0% |
| 2022 FY | -48.6 Million USD | -179.31% |
| 2021 FY | -17.4 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 2905.506% |
| Alkermes plc | -166.73 Million USD | 1041.232% |
| Agenus Inc. | 274.13 Million USD | -472.49% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 16.072% |
| Aptorum Group Limited | 1.35 Million USD | -115548.254% |
| Ardelyx, Inc. | 34.51 Million USD | -4447.404% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -36568.224% |
| Bicycle Therapeutics plc | -481.46 Million USD | 425.962% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -4239.795% |
| ChromaDex Corporation | -24.04 Million USD | 6626.114% |
| Chimerix, Inc. | -25.51 Million USD | 6250.41% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -22422.716% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 6728.374% |
| CRISPR Therapeutics AG | -150.84 Million USD | 1140.406% |
| Precision BioSciences, Inc. | -85.41 Million USD | 1937.49% |
| Dyadic International, Inc. | -6.37 Million USD | 24706.078% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 9949.997% |
| Fortress Biotech, Inc. | 7.66 Million USD | -20374.886% |
| Lantern Pharma Inc. | -21.7 Million USD | 7331.166% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 1519.796% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 18470.217% |
| Incyte Corporation | -3.17 Billion USD | 149.429% |
| IO Biotech, Inc. | -140.69 Million USD | 1215.431% |
| Jaguar Health, Inc. | 29.39 Million USD | -5239.73% |
| Novavax, Inc. | -298.29 Million USD | 626.125% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -29306.033% |
| Opthea Limited | 28.15 Million USD | -5473.659% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 9447.787% |
| ContextLogic Inc. | -232 Million USD | 776.466% |
| MiMedx Group, Inc. | -33.9 Million USD | 4729.362% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -15293.821% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 67833.35% |
| NextCure, Inc. | -6.47 Million USD | 24330.354% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 3207.661% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 24702.602% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -12802.783% |
| Vaxcyte, Inc. | -368.22 Million USD | 526.204% |
| PDS Biotechnology Corporation | -32.7 Million USD | 4898.082% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -8983.227% |
| Pharming Group N.V. | 109.8 Million USD | -1329.274% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 9121.614% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 995.623% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 8574.148% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 8574.148% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 22204.225% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 26881.57% |
| Acelyrin, Inc. | -216.9 Million USD | 823.549% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 28073.713% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 91132.483% |
| Summit Therapeutics Inc. | 34.67 Million USD | -4426.158% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 23169.234% |
| Senti Biosciences, Inc. | 1.74 Million USD | -90095.402% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 950.13% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 2126.313% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 25989.145% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -1572933.708% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -249804.459% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 1440.84% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 1032.873% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -1315.532% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 20760.874% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 1315.515% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -22662.748% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 747.541% |
| Immix Biopharma, Inc. | -17.5 Million USD | 9062.985% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 595.543% |
| MEI Pharma, Inc. | -3.7 Million USD | 42458.974% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -12444.161% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -870.311% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -5546.746% |
| Fortress Biotech, Inc. | 7.66 Million USD | -20374.886% |
| Precigen, Inc. | -481 Thousand USD | 326378.586% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -11045.515% |
| AlloVir, Inc. | -62.69 Million USD | 2603.35% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 2921.951% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -2445.0% |
| ImmuCell Corporation | 10.99 Million USD | -14179.525% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 1118.126% |
| Onconetix, Inc. | 5.33 Million USD | -29336.717% |
| PureTech Health plc | -167.19 Million USD | 1038.653% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 5252.331% |
| Elevation Oncology, Inc. | -19.11 Million USD | 8309.018% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 32069.851% |
| Seer, Inc. | -4.24 Million USD | 37114.151% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 6629.101% |
| Innoviva, Inc. | 255.56 Million USD | -514.095% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 2909.323% |
| ESSA Pharma Inc. | -33.62 Million USD | 4767.835% |
| GlycoMimetics, Inc. | -40.98 Million USD | 3929.259% |
| GT Biopharma, Inc. | -1.02 Million USD | 153812.047% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 2415.33% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -2461.993% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 1270.504% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 11426.501% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 5535.716% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 2083355.9% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 5185.218% |
| Aptose Biosciences Inc. | -8.19 Million USD | 19251.036% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 50256.311% |
| Soligenix, Inc. | -4.95 Million USD | 31794.825% |
| Century Therapeutics, Inc. | 847 Thousand USD | -185189.256% |
| Kura Oncology, Inc. | -20.11 Million USD | 7900.974% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 3934.726% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 18787.783% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -86050.536% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 49189.772% |
| Autolus Therapeutics plc | -186.59 Million USD | 941.055% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 3283.109% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 669.048% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -4479.783% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -854.809% |
| GRI Bio, Inc. | -1.79 Million USD | 87580.491% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 17570.689% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 4819.007% |
| IGM Biosciences, Inc. | -72.6 Million USD | 2261.529% |
| INmune Bio, Inc. | -25.41 Million USD | 6276.065% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -939.675% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 3197.968% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 9758.219% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 54500.009% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -4028.37% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 3910.611% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -4822.064% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -315.239% |
| Verastem, Inc. | -37.27 Million USD | 4309.99% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 17397.476% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 3126.108% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 10469.343% |
| Histogen Inc. | -7.48 Million USD | 21061.667% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 7363.447% |
| Surrozen, Inc. | -32.66 Million USD | 4904.678% |
| Organovo Holdings, Inc. | -1.5 Million USD | 104240.677% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 37435.66% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -8177.335% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -59892.355% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -37662.271% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 18825.354% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 3712.633% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 10866.379% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 595.409% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 217450.359% |
| Apollomics, Inc. | -27.39 Million USD | 5828.783% |
| Amarin Corporation plc | -191.04 Million USD | 921.503% |
| Mesoblast Limited | 55.96 Million USD | -2704.353% |
| Turnstone Biologics Corp. | -14.58 Million USD | 10861.108% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 6305.124% |
| Synaptogenix, Inc. | -28.66 Million USD | 5575.638% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 167770.94% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -3120.471% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 182146.169% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 21698.991% |
| Exelixis, Inc. | -73.05 Million USD | 2248.392% |
| Better Therapeutics, Inc. | -860 Thousand USD | 182588.372% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 6635.627% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 750.202% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -213114.576% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 21199.375% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -125051.515% |
| Gritstone bio, Inc. | 39.49 Million USD | -3874.171% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 1966.09% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 59724.488% |
| Avid Bioservices, Inc. | 169.72 Million USD | -824.656% |
| Insmed Incorporated | 721.62 Million USD | -117.483% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 17267.838% |
| MediWound Ltd. | -5.32 Million USD | 29588.914% |
| OmniAb, Inc. | 9.2 Million USD | -16953.135% |
| Alector, Inc. | -35.63 Million USD | 4503.85% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -1725.499% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 31946.591% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -11754.37% |
| Zai Lab Limited | -775 Million USD | 302.503% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -360.836% |
| Aura Biosciences, Inc. | -21.52 Million USD | 7391.057% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 2002.764% |
| Immunic, Inc. | -45.34 Million USD | 3561.403% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 912.256% |
| Veracyte, Inc. | -203.82 Million USD | 869.978% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | -145.874% |
| FibroGen, Inc. | 56.76 Million USD | -2664.634% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -17523.807% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 55613.07% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 75903.681% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 65.811% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 47073.96% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 1045.627% |
| TG Therapeutics, Inc. | 17.86 Million USD | -8686.25% |
| Galecto, Inc. | -21.21 Million USD | 7497.247% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 6698.276% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 6513.043% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 13738.655% |
| XBiotech Inc. | -200.02 Million USD | 884.61% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 1966.09% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -34559.894% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 4550.557% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 2132.428% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -27476.876% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 1020.928% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 1798.963% |
| Vaxxinity, Inc. | 10.13 Million USD | -15389.538% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | -113.157% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 14675.273% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 2479.465% |
| NexImmune, Inc. | -3.13 Million USD | 50182.284% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 45554.638% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 10485.502% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 5891.144% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 17584.3% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 1259903.331% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 3968.185% |
| Ainos, Inc. | 4.07 Million USD | -38385.231% |
| Pluri Inc. | 22.82 Million USD | -6774.589% |
| Prothena Corporation plc | -608.34 Million USD | 357.978% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 1421.533% |
| Celularity Inc. | 65.19 Million USD | -2307.424% |
| Rallybio Corporation | -24.1 Million USD | 6611.493% |
| Cue Biopharma, Inc. | -33.81 Million USD | 4740.587% |
| MeiraGTx Holdings plc | -40.3 Million USD | 3994.1% |
| Omeros Corporation | 331.17 Million USD | -373.887% |
| Humacyte, Inc. | -22.48 Million USD | 7079.454% |
| Immunocore Holdings plc | -358.59 Million USD | 537.654% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 6486.165% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 5178.8% |
| Blueprint Medicines Corporation | 702.83 Million USD | -123.295% |
| CalciMedica, Inc. | -5.53 Million USD | 28479.747% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 933.811% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 15465.185% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 4019.874% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 4819.574% |
| Pulmatrix, Inc. | -10.41 Million USD | 15165.758% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 26357.32% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 4214.624% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 1508.772% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 2718.11% |
| Cytokinetics, Incorporated | 642.37 Million USD | -144.313% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 27051.743% |
| Nutriband Inc. | -251.65 Thousand USD | 623726.603% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 4699.783% |
| Vor Biopharma Inc. | 4.3 Million USD | -36397.674% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 126.001% |
| Evogene Ltd. | -19.63 Million USD | 8093.277% |
| ProKidney Corp. | -56.23 Million USD | 2890.739% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 3324.441% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 17090.021% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | -15.067% |
| CorMedix Inc. | -43.05 Million USD | 3745.316% |
| BioLineRx Ltd. | 7.33 Million USD | -21293.13% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 5814.182% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -3300.871% |
| Atai Life Sciences N.V. | -28.55 Million USD | 5595.483% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -70259.991% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 6978.506% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -8749.168% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 2190.471% |
| MediciNova, Inc. | -50.78 Million USD | 3190.373% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 2091.498% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 6976761.48% |
| GeoVax Labs, Inc. | -6.45 Million USD | 24422.02% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 885.403% |
| Biomea Fusion, Inc. | -166.57 Million USD | 1042.186% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 976.882% |
| Mereo BioPharma Group plc | -51.46 Million USD | 3149.214% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 1754.717% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 634.247% |
| Absci Corporation | -72.59 Million USD | 2261.768% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -34271.441% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 769.434% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 1765.835% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 1739.985% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 4116.584% |
| Allakos Inc. | -24.97 Million USD | 6383.884% |
| Imunon, Inc. | -4.21 Million USD | 37343.833% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 10745.774% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 1259.084% |
| BioAtla, Inc. | -109.01 Million USD | 1539.671% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -213114.576% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 167235.25% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -13015.494% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 7501.783% |
| XOMA Corporation | -29 Million USD | 5511.724% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 9577.053% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 17506.832% |
| aTyr Pharma, Inc. | -7.44 Million USD | 21168.6% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 1359.187% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 853.925% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 2019.075% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 1791.838% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 182761.688% |
| Akari Therapeutics, Plc | -3.84 Million USD | 40916.645% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -96604.028% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | -13.652% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 132189.367% |
| UroGen Pharma Ltd. | 4.39 Million USD | -35641.289% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -1282.963% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -2180773.239% |
| Orgenesis Inc. | 21.78 Million USD | -7104.37% |
| Entera Bio Ltd. | -10.62 Million USD | 14865.265% |
| GH Research PLC | -78.07 Million USD | 2110.067% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 7141.457% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 5986.942% |
| Xencor, Inc. | 29.64 Million USD | -5194.157% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 79772.578% |
| Replimune Group, Inc. | 1.41 Million USD | -111047.309% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 640912.06% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 1341.447% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 132189.367% |
| Portage Biotech Inc. | -4.98 Million USD | 31607.729% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 6976761.48% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 2473.491% |
| OncoCyte Corporation | -6.56 Million USD | 24012.845% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -174780.462% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 34549.583% |
| Purple Biotech Ltd. | -14.13 Million USD | 11200.58% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 6706.331% |
| scPharmaceuticals Inc. | -6.54 Million USD | 24078.61% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 9502.016% |
| HilleVax, Inc. | -165.48 Million USD | 1048.364% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 61936.091% |
| Tharimmune, Inc. | -10.93 Million USD | 14451.618% |
| Genprex, Inc. | -6.73 Million USD | 23393.061% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 525.534% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 1874.135% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 112119.986% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 47414.608% |
| OKYO Pharma Limited | -826.84 Thousand USD | 189905.14% |
| Savara Inc. | 153 Thousand USD | -1025651.634% |
| Curis, Inc. | -23.88 Million USD | 6670.101% |
| Daré Bioscience, Inc. | -5.15 Million USD | 30527.047% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 202339.141% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 25380.284% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -132338.819% |
| BeiGene, Ltd. | -2.25 Billion USD | 169.656% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -12619.536% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 358.038% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 945.646% |
| Erasca, Inc. | -37.21 Million USD | 4317.003% |
| bluebird bio, Inc. | 108.57 Million USD | -1345.506% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 121957.949% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -314.365% |
| DBV Technologies S.A. | -126.98 Million USD | 1335.884% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 121957.949% |
| Moderna, Inc. | -2.9 Billion USD | 153.987% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 15260.355% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 14540.559% |
| Molecular Templates, Inc. | 707 Thousand USD | -221880.198% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 5102.71% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -352.788% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 2012.456% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 1810.891% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 4963.039% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 4665.394% |
| MacroGenics, Inc. | -66.98 Million USD | 2442.913% |
| RenovoRx, Inc. | -1.17 Million USD | 133893.691% |
| Adicet Bio, Inc. | -138.78 Million USD | 1230.798% |
| Prime Medicine, Inc. | -27.94 Million USD | 5716.835% |
| Aditxt, Inc. | 18.12 Million USD | -8560.725% |
| Adagene Inc. | -87.62 Million USD | 1890.993% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 37776.801% |
| Quantum-Si incorporated | -118.55 Million USD | 1423.751% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -4258.839% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 21097.599% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 3335.276% |
| SciSparc Ltd. | -2.06 Million USD | 76100.0% |
| Vericel Corporation | 1.27 Million USD | -122797.416% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 13187.384% |
| Minerva Neurosciences, Inc. | 41 Million USD | -3727.408% |
| Generation Bio Co. | 31.44 Million USD | -4890.46% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 994.939% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 5175.187% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -1246.05% |
| Invivyd, Inc. | -198.47 Million USD | 890.725% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 1838.562% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 65554.714% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 2316.98% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 23094.872% |
| 2seventy bio, Inc. | 181.71 Million USD | -763.66% |
| ADMA Biologics, Inc. | 90.06 Million USD | -1642.5% |
| Clene Inc. | 3.34 Million USD | -46888.024% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 17378.997% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 7395.802% |
| GeoVax Labs, Inc. | -6.45 Million USD | 24422.02% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 556.057% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 6136.227% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -783.343% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 38456.942% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -31275.45% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 30228.624% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 1304.414% |
| Evaxion Biotech A/S | 5.28 Million USD | -29585.007% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 1494.18% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 1295.524% |
| Trevena, Inc. | 2.25 Million USD | -69403.986% |
| Surrozen, Inc. | -32.66 Million USD | 4904.678% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 3146.787% |
| Cingulate Inc. | 3.08 Million USD | -50810.197% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 53535.478% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -21736.65% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 16991.203% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 2078.493% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 1293.896% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 1586.991% |
| Clearmind Medicine Inc. | -3.94 Million USD | 39905.846% |
| Kronos Bio, Inc. | -36.05 Million USD | 4452.915% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -16579.775% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -107531.228% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 2992.583% |
| Statera Biopharma, Inc. | 14.41 Million USD | -10786.208% |
| ImmunityBio, Inc. | 618.22 Million USD | -153.856% |
| Korro Bio, Inc. | -132.94 Million USD | 1280.506% |
| Kineta, Inc. | -4.54 Million USD | 34660.669% |
| BioVie Inc. | -17.73 Million USD | 8950.49% |
| Codexis, Inc. | -43.27 Million USD | 3726.909% |
| Celularity Inc. | 65.19 Million USD | -2307.424% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 49623.509% |
| Celcuity Inc. | 6.78 Million USD | -23035.519% |
| Virax Biolabs Group Limited | -3.36 Million USD | 46739.706% |
| Cibus, Inc. | -8.07 Million USD | 19528.076% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 37210.428% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -34241.357% |
| IN8bio, Inc. | -16.38 Million USD | 9675.935% |
| Kodiak Sciences Inc. | -103.87 Million USD | 1610.854% |
| Annexon, Inc. | -193.75 Million USD | 909.992% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -4359344.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 9068.512% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 44774.068% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | -48.861% |
| Eyenovia, Inc. | 1.25 Million USD | -124584.0% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -5733.117% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 48493.463% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 4820.426% |
| Arcellx, Inc. | -296.95 Million USD | 628.492% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 8145.73% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 2765.648% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 7671.766% |
| Moolec Science SA | 117.61 Thousand USD | -1334242.266% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 4187.086% |
| Geron Corporation | 14.76 Million USD | -10532.071% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 4238.931% |
| Royalty Pharma plc | 5.65 Billion USD | 72.264% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 1209.736% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 22553.925% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 29364.241% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 1215.177% |
| Humacyte, Inc. | -22.48 Million USD | 7079.454% |
| Structure Therapeutics Inc. | -124.33 Million USD | 1362.194% |
| 89bio, Inc. | -289.05 Million USD | 642.945% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 6317.415% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 88120.191% |
| Genelux Corporation | -6.89 Million USD | 22848.224% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 5152.964% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -1777.295% |
| Notable Labs, Ltd. | -9.77 Million USD | 16153.601% |
| Liquidia Corporation | -80.17 Million USD | 2057.444% |
| Mustang Bio, Inc. | -3.73 Million USD | 42107.495% |
| Immunovant, Inc. | -635.22 Million USD | 347.061% |
| Quantum-Si incorporated | -118.55 Million USD | 1423.751% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 9035.322% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 37980.763% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -19451.514% |
| Acasti Pharma Inc. | -23 Million USD | 6921.995% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 46708.057% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 9758.219% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 1239.393% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 50460.003% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 7159.194% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 8551.721% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 1027.114% |
| PepGen Inc. | -60.67 Million USD | 2686.781% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 6930.606% |
| United Therapeutics Corporation | -507.7 Million USD | 409.12% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 8305.584% |
| Solid Biosciences Inc. | -47.75 Million USD | 3386.702% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 182146.169% |
| Immuneering Corporation | -54.94 Million USD | 2956.422% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 37435.66% |
| Silo Pharma, Inc. | -3.52 Million USD | 44630.728% |
| Belite Bio, Inc | -87.27 Million USD | 1898.306% |
| XOMA Corporation | -29 Million USD | 5511.724% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 2319.896% |
| Bionomics Limited | 227 Million USD | -591.336% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 1449.65% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 62058.152% |
| uniQure N.V. | -102.95 Million USD | 1624.415% |
| Cassava Sciences, Inc. | -121.13 Million USD | 1395.569% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 37776.801% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -3732.385% |
| Forte Biosciences, Inc. | -11.96 Million USD | 13220.977% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 50820.703% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -1480466.038% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 48493.463% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -17523.807% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 21262.352% |
| Altimmune, Inc. | -134.48 Million USD | 1266.953% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -692.366% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 62058.152% |
| Compugen Ltd. | -12.9 Million USD | 12262.12% |
| Peak Bio, Inc. | 10.34 Million USD | -15077.718% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 554658.304% |
| Benitec Biopharma Inc. | -50.58 Million USD | 3202.685% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 1604.15% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -7888.801% |
| Zura Bio Limited | -99.8 Million USD | 1672.451% |
| PolyPid Ltd. | 6.17 Million USD | -25335.981% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -2017.377% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -7888.801% |
| Instil Bio, Inc. | 75.35 Million USD | -1982.592% |
| argenx SE | -2.02 Billion USD | 177.354% |
| Immunome, Inc. | -97.02 Million USD | 1717.455% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 7076.661% |
| Verona Pharma plc | -220.44 Million USD | 811.93% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 2287.53% |
| Shattuck Labs, Inc. | -121.42 Million USD | 1392.496% |
| CervoMed Inc. | -7.79 Million USD | 20238.984% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 946.042% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 35988.406% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 1291.286% |
| Moolec Science SA | 117.61 Thousand USD | -1334242.266% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 68693.347% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -9771.446% |
| AnaptysBio, Inc. | -18.15 Million USD | 8746.356% |
| Design Therapeutics, Inc. | -18.15 Million USD | 8746.832% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 2329.863% |
| NeurAxis, Inc. | 145.7 Thousand USD | -1077044.818% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -13872.578% |
| Lumos Pharma, Inc. | -28.49 Million USD | 5608.02% |
| Achilles Therapeutics plc | -126.92 Million USD | 1336.488% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 2287.53% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 239436.312% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 7654.699% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -107531.228% |
| Nutriband Inc. | -251.65 Thousand USD | 623726.603% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 12015.572% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 21194.086% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -361.321% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -6512.176% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 450.726% |
| Palisade Bio, Inc. | -12.06 Million USD | 13110.031% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 1218.515% |
| Beam Therapeutics Inc. | -262.72 Million USD | 697.361% |
| Neurogene Inc. | -131.95 Million USD | 1289.345% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -7093.803% |
| AEON Biopharma, Inc. | -4.88 Million USD | 32259.836% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 516.076% |
| Sesen Bio, Inc. | -112.55 Million USD | 1494.365% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 1671.6% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 66945.757% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 4121.422% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 1984.441% |
| Athira Pharma, Inc. | -88.99 Million USD | 1863.391% |
| Vaccinex, Inc. | -1.28 Million USD | 121947.826% |
| HCW Biologics Inc. | 2.85 Million USD | -54837.977% |
| XOMA Corporation | -29 Million USD | 5511.724% |
| Nektar Therapeutics | 210.24 Million USD | -646.48% |
| Arvinas, Inc. | -313.8 Million USD | 600.127% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -96604.028% |
| Merus N.V. | -192.88 Million USD | 913.65% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -2516.321% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 22720.352% |
| Rezolute, Inc. | -68.16 Million USD | 2402.253% |
| Clene Inc. | 3.34 Million USD | -46888.024% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 12001.115% |
| BeyondSpring Inc. | -13.75 Million USD | 11509.669% |
| Synlogic, Inc. | -6.68 Million USD | 23576.44% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -138295.062% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 18661.798% |
| Peak Bio, Inc. | 10.34 Million USD | -15077.718% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 2004.149% |
| Krystal Biotech, Inc. | -350.23 Million USD | 548.1% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -1164.371% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 1028.661% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 49809.484% |
| MannKind Corporation | 143.89 Million USD | -990.626% |
| Ikena Oncology, Inc. | -109.15 Million USD | 1537.759% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 20829.098% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 4841.39% |
| Gossamer Bio, Inc. | 180.35 Million USD | -770.173% |
| CohBar, Inc. | -5.93 Million USD | 26562.168% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 5375.649% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -34271.441% |
| Legend Biotech Corporation | -949.39 Million USD | 265.305% |
| Mural Oncology plc | -255.84 Million USD | 713.423% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -4771.644% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 33416.053% |
| Disc Medicine, Inc. | -358.28 Million USD | 538.036% |
| Champions Oncology, Inc. | 4.81 Million USD | -32514.298% |
| REGENXBIO Inc. | 54.76 Million USD | -2765.542% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 583721.847% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 1139.173% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 17514.547% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 2045.143% |
| Vaxart, Inc. | -8.24 Million USD | 19143.805% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 3227.543% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 1334.138% |
| Cellectis S.A. | -43.85 Million USD | 3678.611% |
| Longeveron Inc. | -2.9 Million USD | 54068.363% |
| Repare Therapeutics Inc. | -107.85 Million USD | 1555.061% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | -62.065% |
| Inozyme Pharma, Inc. | 12 Million USD | -12973.975% |
| Revolution Medicines, Inc. | -608.2 Million USD | 358.038% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 127693.496% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 691.965% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 1145.765% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 10130.038% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 212181.081% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 116.41% |
| Denali Therapeutics Inc. | -74.86 Million USD | 2196.307% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 13187.384% |
| Veru Inc. | 4.77 Million USD | -32732.849% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 14055.184% |
| Cingulate Inc. | 3.08 Million USD | -50810.197% |
| Passage Bio, Inc. | 4.58 Million USD | -34129.008% |
| Context Therapeutics Inc. | -14.44 Million USD | 10961.03% |
| Exicure, Inc. | 5.84 Million USD | -26731.937% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 781.234% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 4066.136% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -9901.912% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 2768.095% |
| Nuvalent, Inc. | -335.38 Million USD | 567.937% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -90389.702% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 2207.086% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 17753.543% |
| OmniAb, Inc. | 9.2 Million USD | -16953.135% |
| Anew Medical, Inc. | 1.43 Million USD | -109459.396% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -9480.17% |
| Lipocine Inc. | -4.75 Million USD | 33108.09% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 1528.962% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -10203.985% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 3197.968% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -6204.837% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 23450.692% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 2484.128% |
| Ocugen, Inc. | -32.52 Million USD | 4925.805% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 1933.947% |
| Q32 Bio Inc. | -37.94 Million USD | 4235.659% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 250004.459% |
| Alumis Inc. Common Stock | -13.52 Million USD | 11700.266% |
| Equillium, Inc. | -22.39 Million USD | 7108.753% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 6238.141% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 4910.161% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 633139.55% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -1070.827% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -48974.422% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -477733.157% |
| Dominari Holdings Inc. | 195 Thousand USD | -804720.513% |
| Edesa Biotech, Inc. | -5.26 Million USD | 29897.357% |
| vTv Therapeutics Inc. | -8.91 Million USD | 17700.09% |
| Bio-Techne Corporation | 267.74 Million USD | -486.15% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 9782.275% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 1428.941% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 18776.663% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 12505.343% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 740.26% |
| Nkarta, Inc. | 57.29 Million USD | -2638.966% |
| BioCardia, Inc. | 212 Thousand USD | -740183.019% |
| Iterum Therapeutics plc | 13.43 Million USD | -11578.821% |